Electroencephalographic seizures in critically ill children: Management and adverse events.
France W Fung, Marin Jacobwitz, Lisa Vala...
https://pubmed.ncbi.nlm.nih.gov/31538340/Actively Recruiting
Led by Children's Hospital of Philadelphia · Updated on 2026-06-29
2500
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to study electrographic seizures in critically ill children in the Pediatric ICU, focusing on identifying risk factors and evaluating current seizure management strategies. The study is a single-center, prospective observational trial conducted at the Childrens Hospital of Philadelphia CHOP. It seeks to develop prediction models to guide EEG monitoring resources toward children at highest risk for seizures and to assess the safety of the seizure management pathway used at CHOP. Children enrolled in this study undergo clinically indicated continuous EEG monitoring to detect electrographic seizures. Some participants may receive seizure management based on standard clinical decisions guided by the CHOP ICU EEG Monitoring Pathway. The study tracks these patients to understand seizure occurrence and the safety of current management practices without altering or assigning treatments. Participants are observed during their EEG monitoring period, and data are collected on seizure occurrence within 3 days. Safety outcomes including mortality, cardiopulmonary adverse effects, organ dysfunction, and hospital-acquired infections are monitored for 5 days. The study involves reviewing clinical data without additional interventions, aiming to improve understanding of seizure risk and management in critically ill children over the study duration.
CONDITIONS
Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
N
Nicholas S Abend, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Hospital of Philadelphia
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 days
Participants undergo clinically indicated continuous EEG monitoring as part of their medical care. Researchers observe seizure occurrence and safety outcomes without changing treatment.
Continuous monitoring during ICU stay
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
France W Fung, Marin Jacobwitz, Lisa Vala...
https://pubmed.ncbi.nlm.nih.gov/31538340/France W Fung, Darshana S Parikh, Maureen Donnelly...
https://pubmed.ncbi.nlm.nih.gov/38194638/France W Fung, Darshana S Parikh, Maureen Donnelly...
https://pubmed.ncbi.nlm.nih.gov/36893385/France W Fung, Darshana S Parikh, Shavonne L Massey...
https://pubmed.ncbi.nlm.nih.gov/38079254/France W Fung, Marin Jacobwitz, Darshana S Parikh...
https://pubmed.ncbi.nlm.nih.gov/32077099/France W Fung, Jiaxin Fan, Darshana S Parikh...
https://pubmed.ncbi.nlm.nih.gov/35512186/France W Fung, Darshana S Parikh, Marin Jacobwitz...
https://pubmed.ncbi.nlm.nih.gov/33063870/France W Fung, Jiaxin Fan, Lisa Vala...
https://pubmed.ncbi.nlm.nih.gov/32690798/France W Fung, Zi Wang, Darshana S Parikh...
https://pubmed.ncbi.nlm.nih.gov/33893203/France W Fung, Darshana S Parikh, Shavonne L Massey...
https://pubmed.ncbi.nlm.nih.gov/34642942/Children's Hospital of Philadelphia
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor